Insider Transactions by Ruffo Frank

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMar 10, 2022Sale$15.5512,823199,335201,883Mar 14, 2022, 04:56 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerFeb 09, 2022Sale$12.661,38817,568172,359Feb 11, 2022, 04:18 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerJun 02, 2021Sale$21.6415,037325,383172,322Jun 02, 2021, 09:43 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerApr 26, 2021Sale$25.8027,339705,228151,820Apr 26, 2021, 09:45 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerApr 22, 2021Sale$26.8430,000805,218209,059Apr 26, 2021, 09:45 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerApr 23, 2021Sale$26.6630,000799,660179,859Apr 26, 2021, 09:45 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMar 01, 2021Option Exercise$24.067,333176,432233,606Mar 03, 2021, 08:36 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMar 02, 2021Option Exercise$23.252,84466,123239,059Mar 03, 2021, 08:36 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerFeb 01, 2021Option Exercise$21.351,30827,926215,189Feb 03, 2021, 05:29 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 15, 2020Option Exercise$4.593701,698212,622Dec 17, 2020, 05:07 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerJun 01, 2020Option Exercise$1.329,45112,475211,692Jun 03, 2020, 04:45 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMar 02, 2020Option Exercise$1.267,1629,024187,955Mar 04, 2020, 04:30 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerFeb 03, 2020Option Exercise$1.281,3081,674169,367Feb 04, 2020, 07:12 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 18, 2019Option Exercise$1.81356644166,800Dec 20, 2019, 04:18 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 16, 2019Option Exercise$1.80370666165,906Dec 18, 2019, 11:02 AM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerFeb 01, 2019Option Exercise$6.961,3089,104164,976Feb 05, 2019, 06:31 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 18, 2018Option Exercise$6.303562,243162,409Dec 21, 2018, 07:34 AM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 15, 2018Option Exercise$7.313702,705161,515Dec 18, 2018, 08:54 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMay 07, 2018Option Exercise$18.101,48026,788160,585May 09, 2018, 04:20 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerMay 07, 2018Buy$18.221,25022,775156,865May 07, 2018, 04:28 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerApr 06, 2018Buy$16.591,25020,738155,615Apr 09, 2018, 04:51 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 15, 2017Option Exercise$24.233959,571144,477Dec 21, 2017, 04:57 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 18, 2017Option Exercise$24.123809,166145,347Dec 21, 2017, 04:57 PM
ACRSAclaris Therapeutics, Inc.Ruffo FrankChief Financial OfficerDec 18, 2016Option Exercise$31.2538011,875143,572Dec 20, 2016, 06:51 PM